CDT EQUITY INC.

CDTTW ·Health Care, Pharmaceutical Preparations, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022
Operating Activities
Net Income $-39.2M $-17.8M $-535.0K $-4.9M
Depreciation & Amortization
Depreciation $10.0K
Amortization
Stock-Based Compensation $2.2M $1.6M $199.0K
Net Cash from Operating Activities $-15.6M $-9.7M $-7.7M $-2.3M
Investing Activities
Capital Expenditures $51.0K
Business Acquisitions
Net Cash from Investing Activities $-808.0K $-43.0K $725.0K $-183.0K
Financing Activities
Dividends Paid
Stock Repurchases $106.0K
Net Cash from Financing Activities $17.4M $6.1M $10.9M $2.4M
Net Change in Cash $955.0K $-3.7M $4.2M $297.2K
Free Cash Flow $-9.7M